Patients cured of colorectal cancer: "All patients went into remission, without severe side effects"

Patients cured of colorectal cancer: “All patients went into remission, without severe side effects”

The use of the antibody dostarlimab has enabled 18 patients with colorectal cancer to achieve a cure, according to a study published Sunday in the United States. Jean-Baptiste Bachet, oncologist at Pitié-Salpêtrière, deciphers the advances that this therapy can offer. A revolutionary clinical trial? Published Sunday in the New England Journal of Medicine, a clinical …

Patients cured of colorectal cancer: “All patients went into remission, without severe side effects” Read More »